Optimization of (177)Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application

BACKGROUND: (177)Lu-radiopharmaceuticals are routinely used for the treatment of various tumor entities. The productions of radiopharmaceuticals follow strict good-manufacturing practice guidelines and synthesis optimizations thereof have a strong impact on e.g. the quality of the product, radiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cankaya, Aylin, Balzer, Matthias, Amthauer, Holger, Brenner, Winfried, Spreckelmeyer, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219910/
https://www.ncbi.nlm.nih.gov/pubmed/37233924
http://dx.doi.org/10.1186/s41181-023-00196-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219910/
https://www.ncbi.nlm.nih.gov/pubmed/37233924
http://dx.doi.org/10.1186/s41181-023-00196-1

Ejemplares similares